☰

Lia Rosenstein - Publications

Affiliations: 
2016- Psychology Pennsylvania State University, State College, PA, United States 
Tree Info Similar researchers PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Kivity Y, Levy KN, Johnson BN, Rosenstein LK, LeBreton JM. Mentalizing in and out of awareness: A meta-analytic review of implicit and explicit mentalizing. Clinical Psychology Review. 108: 102395. PMID 38320421 DOI: 10.1016/j.cpr.2024.102395  0.687
2023 Dalrymple KL, Wahrer KS, Walsh E, Rosenstein L, Zimmerman M. A Pilot Randomized Controlled Trial of the Feasibility and Acceptability of Acceptance and Commitment Therapy for Comorbid Social Anxiety Disorder in a Routine Practice Setting. Journal of Cognitive Psychotherapy. PMID 37369538 DOI: 10.1891/JCP-2022-0014  0.471
2022 Bliton CF, Rosenstein LK, Pincus AL. Trading Patients: Applying the Alternative Model for Personality Disorders to Two Cases of Borderline Personality Disorder Over Time and Across Therapists. Frontiers in Psychology. 13: 794624. PMID 35237208 DOI: 10.3389/fpsyg.2022.794624  0.387
2019 Levy KN, Draijer N, Kivity Y, Yeomans FE, Rosenstein LK. Transference-Focused Psychotherapy (TFP) Current Treatment Options in Psychiatry. 6: 312-324. DOI: 10.1007/S40501-019-00193-9  0.739
2018 Ellison WD, Rosenstein LK, Morgan TA, Zimmerman M. Community and Clinical Epidemiology of Borderline Personality Disorder. The Psychiatric Clinics of North America. 41: 561-573. PMID 30447724 DOI: 10.1016/J.Psc.2018.07.008  0.699
2018 Rosenstein LK, Ellison WD, Walsh E, Chelminski I, Dalrymple K, Zimmerman M. The role of emotion regulation difficulties in the connection between childhood emotional abuse and borderline personality features. Personality Disorders. PMID 30091618 DOI: 10.1037/Per0000294  0.679
2017 Walsh E, Rosenstein L, Dalrymple K, Chelminski I, Zimmerman M. The Importance of Assessing for Childhood Abuse and Lifetime PTSD in Bariatric Surgery Candidates. Journal of Clinical Psychology in Medical Settings. PMID 29159539 DOI: 10.1007/S10880-017-9518-7  0.546
2017 Zimmerman M, Chelminski I, Dalrymple K, Rosenstein L. Principal diagnoses in psychiatric outpatients with borderline personality disorder: Implications for screening recommendations. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 29: 54-60. PMID 28207916  0.559
2017 Dalrymple KL, Walsh E, Rosenstein L, Chelminski I, Zimmerman M. Modification of the medical exclusion criterion in DSM-5 social anxiety disorder: Comorbid obesity as an example. Journal of Affective Disorders. 210: 230-236. PMID 28064111 DOI: 10.1016/J.Jad.2016.12.055  0.514
2016 Yusufov M, Dalrymple K, Bernstein MH, Walsh E, Rosenstein L, Chelminski I, Zimmerman M. Body mass index, depression, and suicidality: The role of self-esteem in bariatric surgery candidates. Journal of Affective Disorders. 208: 238-247. PMID 27792969 DOI: 10.1016/J.Jad.2016.10.005  0.385
2016 Zimmerman M, Multach MD, Clark HL, Walsh E, Rosenstein LK, Gazarian D. Inclusion/exclusion criteria in late life depression antidepressant efficacy trials. International Journal of Geriatric Psychiatry. PMID 27546477 DOI: 10.1002/Gps.4560  0.368
2016 Zimmerman M, Holst CG, Clark HL, Multach M, Walsh E, Rosenstein LK, Gazarian D. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years. Cns Drugs. PMID 27541608 DOI: 10.1007/S40263-016-0381-0  0.474
2016 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials. Journal of Affective Disorders. 198: 39-42. PMID 27002283 DOI: 10.1016/J.Jad.2016.03.024  0.529
2016 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 Years. Journal of Clinical Psychopharmacology. PMID 26848791 DOI: 10.1097/Jcp.0000000000000466  0.393
2016 Zimmerman M, Multach M, Walsh E, Rosenstein LK, Gazarian D, Clark HL. Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity. Cns Drugs. PMID 26818632 DOI: 10.1007/S40263-016-0314-Y  0.394
2015 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling. Journal of Affective Disorders. 190: 357-361. PMID 26546771 DOI: 10.1016/J.Jad.2015.10.041  0.473
2015 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 Years. Mayo Clinic Proceedings. 90: 1180-6. PMID 26276679 DOI: 10.1016/j.mayocp.2015.06.016  0.372
2015 Dalrymple KL, Martinez J, Rosenstein L, Kneeland ET, Zimmerman M. Psychiatric disorder-weight associations and the moderating effect of sex in an outpatient psychiatric sample. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 27: 108-17. PMID 25954937  0.538
2015 Ellison WD, Rosenstein L, Chelminski I, Dalrymple K, Zimmerman M. The Clinical Significance of Single Features of Borderline Personality Disorder: Anger, Affective Instability, Impulsivity, and Chronic Emptiness in Psychiatric Outpatients. Journal of Personality Disorders. 1-10. PMID 25893552 DOI: 10.1521/Pedi_2015_29_193  0.718
2015 Hidalgo-Mazzei D, Walsh E, Rosenstein L, Zimmerman M. Comorbid bipolar disorder and borderline personality disorder and substance use disorder. The Journal of Nervous and Mental Disease. 203: 54-7. PMID 25494335 DOI: 10.1097/Nmd.0000000000000235  0.603
2015 Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Have Treatment Studies of Depression Become even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published during the Past 20 Years Mayo Clinic Proceedings. 90: 1180-1186. DOI: 10.1016/j.mayocp.2015.06.016  0.382
2014 Zimmerman M, Chelminski I, Young D, Dalrymple K, Walsh E, Rosenstein L. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder. The Journal of Clinical Psychiatry. 75: 601-7. PMID 24813209 DOI: 10.4088/Jcp.13M08961  0.557
1994 Rosenstein LD. Potential neuropsychologic and neurophysiology correlates of multiple personality disorder: Literature review and two case studies Neuropsychiatry, Neuropsychology and Behavioral Neurology. 7: 215-229.  0.393
Show low-probability matches.